Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 family 4 subfamily F member 29, pseudogene (CYP4F29P), is a human pseudogene that is related by sequence similarity to the cytochrome P450 (CYP) superfamily, specifically the family 4, subfamily F proteins[1]. Unlike canonical CYP genes, CYP4F29P does not encode a functional protein due to mutations or disruptions in its coding sequence that render it nonfunctional. As a pseudogene, it lacks known biological or enzymatic activity and is neither considered a drug target nor implicated in disease. Despite sharing sequence homology with the functional enzymes responsible for fatty acid metabolism and drug/xenobiotic oxidation in the cytochrome P450 family[3], CYP4F29P itself is biologically inert and has no known clinical or pharmacological relevance[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 4 subfamily F member 29, pseudogene (CYP4F29P).